Drug Monitoring, Other Illicit Additives, Qualitative, Urine
*Build Your Own Panel Eligible [?]
|
$322
|
|
|
Description:
Other Illicits are compounds designed to mimic the effects of prescription drugs, evade detection by typical drug testing methodologies, and avoid regulation. They are a part of a class of drugs known as Novel Psychoactive Substances (NPS). NPS can also be referred to as legal highs, spice, Benzo Dope, Tranq Dope, or in products labelled "not for human use". NPS markets rapidly change in response to regulation from national and international agencies. These drugs are not typically detected by presumptive, immunoassay point-of-care or desktop analyzer drug tests. NPS may potentiate drug interactions with prescription medications, leading to unintended overdoses. Individuals may be exposed to illicit fentanyl or analogs, designer opoids, stimulants, and benzodiazepines, or xylazine, knowingly, or unknowingly through counterfeit prescription drugs intended to mimic common drugs such as oxycodone, hydrocodone, and alprazolam, among others. Updates and enhancements to our tested drug list are made from time to time based on surveillance data from the Center for Forensic Science Research and Education (CFSRE) and clinical patient trends. A complete and up to date list of the analytes contained in each drug class can be found at the bottom of each report and in our online FAQ.
Categories:
Price:
$322
|
|
Drug Monitoring, Oxycodone, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Oxycodone is a semisynthetic narcotic analgesic that is available in oral formulations, often in combination with other drugs such as acetaminophen. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of oxycodone and its metabolite oxymorphone is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes strategies as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Oxycodone, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Oxycodone is a semisynthetic narcotic analgesic that is available in oral formulations, often in combination with other drugs such as acetaminophen, aspirin, phenacetin, and caffeine. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screening tests are reflexed to amore specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) confirmation test. Therapeutic urine drug monitoring of oxycodone and its metabolite oxymorphone is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes strategies as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Panel 1, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$465
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$465
|
|
Drug Monitoring, Panel 1, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$465
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$465
|
|
Drug Monitoring, Panel 1, with Confirmation, with D/L Isomers, Urine
*Build Your Own Panel Eligible [?]
|
$465
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$465
|
|
Drug Monitoring, Panel 3, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$458
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$458
|
|
Drug Monitoring, Panel 3, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$458
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$458
|
|
Drug Monitoring, Panel 4, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$463
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$463
|
|
Drug Monitoring, Panel 4, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$463
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$463
|
|
Drug Monitoring, Panel 5, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$463
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$463
|
|
Drug Monitoring, Panel 5, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$463
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$463
|
|
Drug Monitoring, Panel 5, with Confirmation, with D/L Isomers, Urine
*Build Your Own Panel Eligible [?]
|
$463
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$463
|
|
Drug Monitoring, Panel 6 with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$470
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$470
|
|
Drug Monitoring, Panel 7 with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$467
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$467
|
|
Drug Monitoring, Panel 8 with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$467
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$467
|
|
Drug Monitoring, Panel 9, with Confirmation, with D/L Isomers, Urine
*Build Your Own Panel Eligible [?]
|
$477
|
|
|
Description:
The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive (LC/MS/MS) test.
Categories:
Price:
$477
|
|
Drug Monitoring, Phencyclidine, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Phencyclidine (PCP, "angel dust") is an illicit psychotropic drug that causes anxiety, disorientation, and acute confusion resembling schizophrenia. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of PCP is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Phencyclidine, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Phencyclidine (PCP, "angel dust") is an illicit psychotropic drug that causes anxiety, disorientation, and acute confusion resembling schizophrenia. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of PCP is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Phencyclidine, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Phencyclidine (PCP, "angel dust") is an illicit psychotropic drug that causes anxiety, disorientation, and acute confusion resembling schizophrenia. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screening tests are reflexed to amore specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) confirmation test. Therapeutic urine drug monitoring of PCP is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Phentermine, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Phentermine is a prescription stimulant. Because taking phentermine comes with a risk of dependence, it is considered a controlled substance. It's chemically similar to the stimulant amphetamine, which is also a controlled substance. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of phentermine is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Phosphatidylethanol (PEth), Blood
*Build Your Own Panel Eligible [?]
|
$392
|
|
|
Description:
Alcohol abuse remains a significant public health challenge in the United States. As a long-term, specific and direct biomarker of alcohol consumption, Phosphatidylethanol (PEth) is a group of phospholipids formed in the presence of ethanol and incorporated into the phospholipid membrane of red blood cells. PEth detection is suggestive of ethanol ingestion over multiple days. PEth is detectable for 1-2 weeks. The predominant PEth homologues are PEth 16:0/18:1 (POPEth) and PEth 16:0/18:2 (PLPEth), which account for 37-46% and 26-28% of the total PEth homologues, respectively.
Categories:
Price:
$392
|
|
Drug Monitoring, Pregabalin, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Pregabalin is used as an adjunct therapy for partial seizures, for the treatment of generalized anxiety disorder, neuropathic pain and fibromyalgia. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of pregabalin is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Propoxyphene, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
d-Propoxyphene is a narcotic analgesic that is structurally related to methadone. The l-isomer is devoid of narcotic effects and is available as an antitussive. The FDA mandated the removal of propoxyphene products used for pain management in 2010. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of propoxyphene is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Propoxyphene, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
d-Propoxyphene is a narcotic analgesic that is structurally related to methadone. The l-isomer is devoid of narcotic effects and is available as an antitussive. The FDA mandated the removal of propoxyphene products used for pain management in 2010. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screening tests are reflexed to amore specific and sensitive liquid chromatography mass spectroscopy LC/MS/MS) confirmation test. Therapeutic urine drug monitoring of propoxyphene is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Synthetic Cannabinoids, Qualitative, Urine
*Build Your Own Panel Eligible [?]
|
$322
|
|
|
Description:
Synthetic Cannabinoids are compounds designed to mimic the effects of prescription drugs, evade detection by typical drug testing methodologies, and avoid regulation. They are a part of a class of drugs known as Novel Psychoactive Substances (NPS). NPS can also be referred to as legal highs, spice, Benzo Dope, Tranq Dope, or in products labelled "not for human use". NPS markets rapidly change in response to regulation from national and international agencies. These drugs are not typically detected by presumptive, immunoassay point-of-care or desktop analyzer drug tests. NPS may potentiate drug interactions with prescription medications, leading to unintended overdoses. Individuals may be exposed to illicit fentanyl or analogs, designer opoids, stimulants, and benzodiazepines, or xylazine, knowingly, or unknowingly through counterfeit prescription drugs intended to mimic common drugs such as oxycodone, hydrocodone, and alprazolam, among others. Updates and enhancements to our tested drug list are made from time to time based on surveillance data from the Center for Forensic Science Research and Education (CFSRE) and clinical patient trends. A complete and up to date list of the analytes contained in each drug class can be found at the bottom of each report and in our online FAQ.
Categories:
Price:
$322
|
|
Drug Monitoring, Tapentadol, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Tapentadol is approved for the treatment of moderate to severe acute pain. Due to its dual mechanism of action as an opioid agonist and norepinephrine reuptake inhibitor, there is potential for ON LABEL for chronic pain. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of tapentadol is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Tramadol, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
This test measures levels of tramadol and its metabolite desmethyltramadol in urine. Tramadol and desmethyltramadol are biomarkers for monitoring possible use or non-use of tramadol. The test is a definitive drug assay using the liquid chromatography/mass spectrometry (LC/MS-MS) method of analysis. Tramadol is an opioid-like analgesic used to treat moderate to moderately severe pain. Approximately 30% of the dose is excreted as unchanged drug, while 60% is excreted as metabolites [1,2]. According to the American Association for Clinical Chemistry (AACC), testing drugs/drug metabolites is recommended and effective for detecting the use of relevant over-the-counter, prescribed, and nonprescribed drugs, as well as illicit substances in pain-management patients [3]. Laboratory testing is more effective than other physician tools for the detection of these substances in pain-management patients and is useful for routine monitoring of adherence. Instances where unchanged drug is detected, but metabolite(s) is not, may be indicative of drug added to the specimen after collection (eg, pill shaving, drug spiking) [3]. Note: No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as quantitative values and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine. References 1. Ultram [package insert]. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc; 2003. 2. Vazzana M, et al. Biomed Pharmacother. 2015;70:234-238. 3. AACC. Using clinical laboratory tests to monitor drug therapy in pain management patients. November 2017. https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Pain-Management/LMPGPain-Management20171220.pdf?la=en&hash=19670524407619F78999AB60731A24CB4901939D. Accessed November 21, 2019.
Categories:
Price:
$326
|
|
Drug Monitoring, Tricyclic Antidepressants, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Amitriptyline and nortriptyline are used to treat various forms of depression and chronic neuropathic pain. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of these drugs is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Zolpidem, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Zolpidem is used to treat patients with insomnia. This test is used to detect the presence of the drug as a therapeutic drug monitoring and to aide clinicians with the drug's dosage effectiveness.
Categories:
Price:
$326
|
|
Drug Screen, Clinical 1, without Confirmation, Serum
*Build Your Own Panel Eligible [?]
|
$388
|
|
|
Description:
This panel may be useful in screening drugs which are commonly encountered in acute toxicity cases. See individual tests for additional clinical significance. See specimen collection guide for additional drug screens.
Categories:
Price:
$388
|
|
Drug Screen Panel 5, Meconium
*Build Your Own Panel Eligible [?]
|
$361
|
|
|
Description:
Meconium contains the amniotic fluid swallowed by the fetus in the last half of pregnancy and is released as the first stools after birth. Meconium is easier to collect than neonatal urine and provides a much longer window of exposure of up to 20 weeks. Meconium is an effective biological marker of in utero drug exposure, and can provide insights leading to improved neonatal outcomes, as well as provide evidence to ensure appropriate rehabilitation of mothers suffering from addiction. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive mass spectroscopy (MS) methodology. Test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the amount of drug that the neonate was exposed.
Categories:
Price:
$361
|
|
Drug Screen Panel 9, Meconium
*Build Your Own Panel Eligible [?]
|
$468
|
|
|
Description:
Meconium contains the amniotic fluid swallowed by the fetus in the last half of pregnancy and is released as the first stools after birth. Meconium is easier to collect than neonatal urine and provides a much longer window of exposure of up to 20 weeks. Meconium is an effective biological marker of in-utero drug exposure, and can provide insights leading to improved neonatal outcomes, as well as provide evidence to ensure appropriate rehabilitation of mothers suffering from addiction. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive mass spectroscopy (MS) methodology. Test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the amount of drug that the neonate was exposed to.
Categories:
Price:
$468
|
|
Drug Test, General Toxicology, Blood
*Build Your Own Panel Eligible [?]
|
$762
|
|
|
Description:
Toxicology screens are used to identify substances affecting a patient and to guide the clinician to predict future toxic effects, to confirm the differential diagnosis or to guide therapy. Accurate diagnosis of clinical intoxication secondary to illicit drug use based on clinical history and physical examination may be difficult without laboratory confirmation. This testing is also necessary when multiple drug ingestion is involved, as the effects of one drug may mask the clinical signs and symptoms of the effects of other drugs.
Categories:
Price:
$762
|
|
Drug Test, General Toxicology, Serum
*Build Your Own Panel Eligible [?]
|
$762
|
|
|
Description:
The general toxicology screen is a mass spectroscopy-based test that is designed with the overdose patient in mind, or where a detailed medical history is not available. The assay tests for over 140 drugs and/or drug metabolites. Many of the substances tested for are prescription and over the counter medications that are not typically screened for in traditional drug tests. Only drug test results equal to or greater than the cutoff are reported. Negative results are not listed on the report. Quantitative results are not available on this test.
Categories:
Price:
$762
|
|
Drug Toxicology Alcohol Metabolites, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Amphetamines, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Barbiturates, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Benzodiazepines, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Cocaine, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Gabapentin, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Gabapentin is used as an anticonvulsant in the management of neuropathic pain in adults and as adjunctive therapy in the treatment of partial seizures in patients with epilepsy. Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Marijuana, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology MDMA, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Meprobamate, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Methadone, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Methylphenidate, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$371
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$371
|
|
Drug Toxicology Monitoring 1, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$637
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$637
|
|
Drug Toxicology Monitoring Alcohol Metabolites, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Ethylglucuronide (EtG) and Ethylsulfate (EtS) are metabolites of ethanol. While EtG has been used as a long-term biomarker in urine testing for more than 7 years, EtS has more recently been incorporated into testing programs. Scientific literature indicates that EtG may be detectable for up to 80 hours and that EtS may be detectable for 24 hours or more after ethanol ingestion - depending on cutoff, metabolism, and usage patterns. Under certain conditions, in-vitro (outside of the body, in the specimen container) formation of EtG may also occur when certain bacteria and ethanol or ethanol-producing bacteria are both present in a urine specimen. No published reports of in-vitro synthesis of EtS exist, however, even under the same conditions in which EtG may be synthesized in-vitro. EtS is typically present in urine at a lower concentration than EtG, although the ratio of EtG to EtS varies significantly between individual donors. In order to be reported positive for EtG, Quest Diagnostics’ clinical reporting criteria require that EtS be present in a specimen at a minimum concentration of 100 ng/mL whenever EtG is present at a concentration greater than or equal to 500 ng/mL. As with EtG, the presence of EtS in a urine specimen does not establish the source of the ethanol containing product and the possibility of "incidental exposure" and post-collection specimen changes needs to be considered when interpreting results. EtG and EtS testing, as with any controlled substance testing, measure only the presence and concentration of EtG (or EtS) in a given urine specimen. Quest Diagnostics recommends clinical correlation and/or healthcare provider review when interpreting EtG and EtS results.
Categories:
Price:
$326
|
|
Drug Toxicology Monitoring Alcohol Metabolites, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Ethyl glucuronide and ethyl sulfate are metabolites of ethanol (alcohol) that may be present in urine after ingestion of, or exposure to, drinks, foods, medication or other products containing ethyl alcohol. Incidental exposure to alcohol-containing products such as mouthwash or hand sanitizer have also been shown to produce positive alcohol metabolites test results. LC-MS/MS testing detects EtG and EtS regardless of the source. Therefore, we encourage you to interpret alcohol metabolite test results in light of the clinical picture.
Categories:
Price:
$446
|
|
Drug Toxicology Monitoring Base Panel, with Confirmation, Oral Fluid
*Build Your Own Panel Eligible [?]
|
$441
|
|
|
Description:
Oral fluid is composed of saliva, mixed with buccal and mucosal transudates, cellular debris, bacteria, and residue of ingested products. Oral fluid as a test matrix shows promise for detection of recent drug use, and a significant body of scientific literature documents drug disposition and detection times. Researchers comparing effectiveness of oral fluid and urine drug testing found a similar pattern and frequency of positive drug test results in the general workforce over the same general period. Similarly in pain clinics, the pattern of licit and illicit drugs and metabolites observed in oral fluid paralleled results reported for urine, with some minor differences in detection rates for different drug classes. In some cases, oral fluid testing may be an acceptable alternative or the only available matrix. As an ultra-filtrate of blood, however, it shares the limitations of a decreased window of detection versus conventional urine drug testing.
Categories:
Price:
$441
|
